Obstructive Sleep Apnea Syndrome (OSA) and Getemed (GETEMED)
Primary Purpose
Sleep Apnea, Obstructive
Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
home polysomnography (GETEMED)
standard polysomnography (BRAINNET II)
Sponsored by
About this trial
This is an interventional diagnostic trial for Sleep Apnea, Obstructive focused on measuring Obstructive Sleep Apnea syndrome, polysomnography, Home monitoring
Eligibility Criteria
Inclusion Criteria:
- Male and female subjects, aged 2 to 6 years old, requiring a polysomnography or admitted for intense snoring or suspected sleep apnea
- Parents must have signed the inform consent form and be covered by the National Health Insurance Program.
Exclusion Criteria:
- Parents opposed to the study.
Sites / Locations
- Hospices Civils de Lyon- Hôpital Femme Mère Enfant
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
home polysomnography and standard polysomnography
Arm Description
home polysomnography (GETEMED) and standard polysomnography (BRAINNETII) are both carried out in children during 1 night.
Outcomes
Primary Outcome Measures
Characteristics of a home polysomnograph versus standard polysomnography for the diagnosis of OSA in children.
Standard polysomnography considered pathological if obstructive apnea-hypopnea index (AHI) > 5 / hr.
Home polysomnography considered pathological if at least one of the following criteria is present :
Respiratory Disturbance Index (RDI) > 10 / hr + /- Desaturation Index > 4% for more than 2.5 / hr.
Brouillette index ; pulse wave > 3 desaturation clusters and > 3 desaturation <90%.
Secondary Outcome Measures
To determine polygraphic pathological criteria by comparing the RDI per hour of the home polysomnography versus the (AHI) of the standard polysomnography.
Full Information
NCT ID
NCT01720823
First Posted
October 31, 2012
Last Updated
April 4, 2016
Sponsor
Hospices Civils de Lyon
1. Study Identification
Unique Protocol Identification Number
NCT01720823
Brief Title
Obstructive Sleep Apnea Syndrome (OSA) and Getemed
Acronym
GETEMED
Official Title
Diagnostic Characteristics of a Home Polysomnograph for the Diagnosis of Patients With Obstructive Sleep Apnea Syndrome - A Pilot Study
Study Type
Interventional
2. Study Status
Record Verification Date
April 2016
Overall Recruitment Status
Completed
Study Start Date
October 2012 (undefined)
Primary Completion Date
January 2016 (Actual)
Study Completion Date
January 2016 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Hospices Civils de Lyon
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
It is often clinically impossible to differentiate children with an isolated snoring from those with OSA. The diagnosis of OSA is currently based on nocturnal, laboratory-based polysomnography. This expensive examination is poorly accessible due to appointments delays at hospital.
Our study is designed to compare the characteristics of a home polysomnography versus standard polysomnography for the diagnosis of pediatric OSA.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Sleep Apnea, Obstructive
Keywords
Obstructive Sleep Apnea syndrome, polysomnography, Home monitoring
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
62 (Actual)
8. Arms, Groups, and Interventions
Arm Title
home polysomnography and standard polysomnography
Arm Type
Experimental
Arm Description
home polysomnography (GETEMED) and standard polysomnography (BRAINNETII) are both carried out in children during 1 night.
Intervention Type
Device
Intervention Name(s)
home polysomnography (GETEMED)
Other Intervention Name(s)
GETEMED
Intervention Type
Device
Intervention Name(s)
standard polysomnography (BRAINNET II)
Other Intervention Name(s)
BRAINNET II
Primary Outcome Measure Information:
Title
Characteristics of a home polysomnograph versus standard polysomnography for the diagnosis of OSA in children.
Description
Standard polysomnography considered pathological if obstructive apnea-hypopnea index (AHI) > 5 / hr.
Home polysomnography considered pathological if at least one of the following criteria is present :
Respiratory Disturbance Index (RDI) > 10 / hr + /- Desaturation Index > 4% for more than 2.5 / hr.
Brouillette index ; pulse wave > 3 desaturation clusters and > 3 desaturation <90%.
Time Frame
1 night
Secondary Outcome Measure Information:
Title
To determine polygraphic pathological criteria by comparing the RDI per hour of the home polysomnography versus the (AHI) of the standard polysomnography.
Time Frame
1 night
10. Eligibility
Sex
All
Minimum Age & Unit of Time
2 Years
Maximum Age & Unit of Time
12 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Male and female subjects, aged 2 to 6 years old, requiring a polysomnography or admitted for intense snoring or suspected sleep apnea
Parents must have signed the inform consent form and be covered by the National Health Insurance Program.
Exclusion Criteria:
Parents opposed to the study.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Patricia FRANCO, MD
Organizational Affiliation
Hospices Civils de Lyon- Hôpital Femme Mère Enfant
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hospices Civils de Lyon- Hôpital Femme Mère Enfant
City
Bron
ZIP/Postal Code
69677
Country
France
12. IPD Sharing Statement
Learn more about this trial
Obstructive Sleep Apnea Syndrome (OSA) and Getemed
We'll reach out to this number within 24 hrs